Citation Impact
Citing Papers
Plaque Instability Frequently Occurs Days or Weeks Before Occlusive Coronary Thrombosis
2005
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis
2015 Standout
Physical and mechanical properties of PLA, and their functions in widespread applications — A comprehensive review
2016 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2003 Standout
Therapeutic advances in myocardial microvascular resistance: Unravelling the enigma
2010
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Hypoxia and Inflammation
2011 Standout
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
Microemboli and Microvascular Obstruction in Acute Coronary Thrombosis and Sudden Coronary Death
2009
Analysis of atherectomy specimens
1993
Differential Sensitivity of Hypoxia Inducible Factor Hydroxylation Sites to Hypoxia and Hydroxylase Inhibitors
2011 StandoutNobel
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
2016 StandoutNobel
Oxygen sensing and hypoxia signalling pathways in animals: the implications of physiology for cancer
2013 StandoutNobel
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Pathophysiological mechanisms for restenosis following coronary angioplasty: possible preventive alternatives
1993
Myocardial Reperfusion Injury
2007 Standout
High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo‐controlled pilot study
2007
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
No-reflow phenomenon and prognosis in patients with acute myocardial infarction
2006
Carotid body hyperplasia and enhanced ventilatory responses to hypoxia in mice with heterozygous deficiency of PHD2
2013 StandoutNobel
Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy—A prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil
2007
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
2014
Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease
2009
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Coronary Stents
2010
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Diabetic Cardiovascular Autonomic Neuropathy
2007
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
Diabetic Cardiomyopathy
2018 Standout
Adipocyte Pseudohypoxia Suppresses Lipolysis and Facilitates Benign Adipose Tissue Expansion
2014 StandoutNobel
Using the shortwave infrared to image middle ear pathologies
2016 StandoutNobel
Mechanisms of Plaque Formation and Rupture
2014 Standout
Microvasculature in Acute Myocardial Ischemia: Part II
2004
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Mechanisms of Diabetic Complications
2013 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury
2010 StandoutNobel
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Detection of Lipid-Core Plaques by Intracoronary Near-Infrared Spectroscopy Identifies High Risk of Periprocedural Myocardial Infarction
2011
Inflammatory Markers at the Site of Ruptured Plaque in Acute Myocardial Infarction
2005
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
2004
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Endothelial Function and Dysfunction
2007 Standout
Works of Tomoki Ohara being referenced
Metabolic changes in hibernating myocardium after percutaneous transluminal coronary angioplasty and the relation between recovery in left ventricular function and free fatty acid metabolism
1998
Angiographic and clinical outcome of a new self-expanding intracoronary stent (RADIUS): Results from multicenter experience in Japan
2000
Visceral abdominal fat accumulation predicts the progression of noncalcified coronary plaque
2012
Abnormal Myocardial Free Fatty Acid Utilization Deteriorates With Morphological Changes in the Hypertensive Heart.
2001
Mechanism of Impaired Left Ventricular Wall Motion in the Diabetic Heart Without Coronary Artery Disease
1998
Plaque Gruel of Atheromatous Coronary Lesion May Contribute to the No-Reflow Phenomenon in Patients With Acute Coronary Syndrome
2002
Ultrastructural study of proliferating and migrating smooth muscle cells at the site of PICA as an explanation for restenosis
1991
Ultrastructural study of restenosis after direct PTCA
1991
Prediction of No-Reflow Phenomenon After Successful Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction
2003
No-Reflow Following Dilatation of a Coronary Lesion With a Large Lipid Core.
2002